Suvretta Capital Management 13F holdings, Q1 2024
Holdings as of March 31, 2024 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 99 US equity positions worth $2.4bn in its Q1 2024 13F filing. The largest position was BHVN at 9.2% of the reported book, followed by KURA and ARCELLX INC. Against the Q4 2023 filing, it opened 9 new positions, added to 10 and reduced 26 among the top 50 holdings.
What did Suvretta Capital Management own in Q1 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2023 |
|---|---|---|---|---|---|---|---|
| 1 | BHVN BIOHAVEN LTD | Healthcare | 9.2% | $218.9m | 4,003,046 | -12% | reduced |
| 2 | KURA KURA ONCOLOGY INC | Healthcare | 6.4% | $150.8m | 7,069,627 | 2% | added |
| 3 | ARCELLX INC | 4.6% | $108.7m | 1,562,354 | -36% | reduced | |
| 4 | META META PLATFORMS INC | Communication Services | 3.6% | $84.3m | 173,605 | -21% | reduced |
| 5 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3.3% | $78.3m | 1,676,811 | -21% | reduced |
| 6 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 3.3% | $78.1m | 7,877,297 | -7% | reduced |
| 7 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 3.3% | $77.8m | 3,763,888 | -7% | reduced |
| 8 | 89BIO INC | 3.1% | $73.3m | 6,298,004 | 29% | added | |
| 9 | RPRX ROYALTY PHARMA PLC | Healthcare | 2.9% | $68.3m | 2,250,361 | -42% | reduced |
| 10 | INTRA-CELLULAR THERAPIES INC | 2.8% | $66.4m | 959,198 | -18% | reduced | |
| 11 | AMZN AMAZON COM INC | Consumer Cyclical | 2.7% | $64.4m | 356,962 | -3% | reduced |
| 12 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.6% | $61.7m | 341,699 | 2% | added |
| 13 | INSM INSMED INC | Healthcare | 2.3% | $54.9m | 2,023,000 | -25% | reduced |
| 14 | CI THE CIGNA GROUP | Healthcare | 2.1% | $49.8m | 137,139 | 42% | added |
| 15 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.1% | $49.7m | 4,192,005 | 56% | added | |
| 16 | VZ VERIZON COMMUNICATIONS INC | Communication Services | 2.1% | $49.5m | 1,179,452 | 65% | added |
| 17 | ARGX ARGENX SE | Healthcare | 2.0% | $48.0m | 121,900 | 127% | added |
| 18 | MARINUS PHARMACEUTICALS INC | 1.9% | $46.2m | 5,108,520 | -4% | reduced | |
| 19 | GS GOLDMAN SACHS GROUP INC | Financial Services | 1.9% | $45.9m | 109,890 | -0% | held |
| 20 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 1.9% | $44.8m | 329,352 | -15% | reduced |
| 21 | T AT&T INC | Communication Services | 1.8% | $42.2m | 2,398,619 | 97% | added |
| 22 | APO APOLLO GLOBAL MGMT INC | Financial Services | 1.8% | $41.7m | 370,636 | -31% | reduced |
| 23 | FERGUSON PLC NEW | 1.6% | $37.0m | 169,280 | -4% | reduced | |
| 24 | GE GENERAL ELECTRIC CO | Industrials | 1.5% | $36.4m | 207,447 | -42% | reduced |
| 25 | KO COCA COLA CO | Consumer Defensive | 1.4% | $33.4m | 546,500 | – | new |
| 26 | MSFT MICROSOFT CORP | Technology | 1.4% | $33.4m | 79,317 | -51% | reduced |
| 27 | STRO SUTRO BIOPHARMA INC | Healthcare | 1.4% | $32.6m | 5,778,188 | 0% | held |
| 28 | MCK MCKESSON CORP | Healthcare | 1.3% | $30.4m | 56,639 | -11% | reduced |
| 29 | AAPL APPLE INC | Technology | 1.3% | $30.3m | 176,680 | – | new |
| 30 | CRH CRH PLC | Basic Materials | 1.2% | $28.9m | 335,580 | – | new |
| 31 | AVBP ARRIVENT BIOPHARMA INC | 1.2% | $27.9m | 1,563,709 | – | new | |
| 32 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.1% | $26.9m | 2,848,486 | -48% | reduced |
| 33 | ELV ELEVANCE HEALTH INC | Healthcare | 1.1% | $26.4m | 50,925 | -5% | reduced |
| 34 | ORCL ORACLE CORP | Technology | 1.0% | $24.7m | 196,674 | -39% | reduced |
| 35 | CMG CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | 1.0% | $23.2m | 7,970 | -8% | reduced |
| 36 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 1.0% | $22.8m | 914,476 | 0% | held |
| 37 | PEPG PEPGEN INC | Healthcare | 0.9% | $22.4m | 1,520,932 | 213% | added |
| 38 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.9% | $20.8m | 303,035 | -56% | reduced |
| 39 | FATE FATE THERAPEUTICS INC | Healthcare | 0.8% | $18.8m | 2,562,852 | – | new |
| 40 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 0.8% | $18.1m | 957,304 | 0% | held |
| 41 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 0.7% | $16.7m | 78,502 | -28% | reduced |
| 42 | CRM SALESFORCE INC | Technology | 0.7% | $16.6m | 55,050 | – | new |
| 43 | SBUX STARBUCKS CORP | Consumer Cyclical | 0.7% | $15.8m | 172,951 | – | new |
| 44 | JNJ JOHNSON & JOHNSON | Healthcare | 0.6% | $14.3m | 90,097 | 0% | held |
| 45 | GPN GLOBAL PMTS INC | Industrials | 0.6% | $14.2m | 106,094 | -6% | reduced |
| 46 | PINS PINTEREST INC | Communication Services | 0.6% | $13.7m | 395,851 | – | new |
| 47 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.5% | $12.1m | 3,653,494 | -50% | reduced |
| 48 | SNY SANOFI | 0.4% | $10.2m | 210,701 | 23% | added | |
| 49 | IMTX IMMATICS N.V | Healthcare | 0.4% | $9.9m | 946,563 | – | new |
| 50 | 430 TERNS PHARMACEUTICALS INC | 0.4% | $8.9m | 1,363,675 | -77% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.